InvestorsHub Logo
Followers 13
Posts 989
Boards Moderated 0
Alias Born 02/17/2006

Re: until2000 post# 87919

Wednesday, 08/22/2012 9:27:46 AM

Wednesday, August 22, 2012 9:27:46 AM

Post# of 346181
From Corsica.

"Naturally, we ASSUME that the May 2012 for the ad one-line NSCLC trial was again not based on independent central review..."

These guys call themselves biotech investment researchers? The key verifiable fact supporting the dismissal of the 2nd-line data in the article and they got it wrong. All they had to do was read the freakin' press release! I guess that was too much work for such a prestigious outfit as Apsara Biotechnology Research. Why would anyone trust any of their other assumptions?

Hatchet job. Transparent.

HR, p-value TBD. Significance, TBD. FDA reaction to the data, TBD.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News